comprehensive -WSS

comprehensive

author：entertainment 2025-08-31 02:00:11 - browse：3

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

explore

WSS

New chief aims to remake Sanofi Genzyme

Pfizer's RSV vaccine recommended for approval in Europe

What is artificial intelligence? Experts weigh in

Colorectal cancer study finds potential in overlooked immune cell

Trump Organization, Michael Cohen agree to settle million

FDA authorizes Novavax’s updated Covid

leisure time

comprehensive

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Apple is now the first public company to be valued at $3 trillion

AI can decode, harness the power of the humane immune system

Apple is now the first public company to be valued at $3 trillion

Phenylephrine and the overlooked value of the placebo effect

Heart attack and stroke risk calculators need revising

A former Republican legislative candidate has been charged for his role in the US Capitol riot

23andMe had bad news about my health. I wish a person had delivered it

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

leisure time

The future of health care in the House

Phenylephrine and the overlooked value of the placebo effect

Was Amgen transparent enough on FDA's concern on cancer drug?

'The View' co

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Colorectal cancer study finds potential in overlooked immune cell

leisure time

explore

leisure time

Wikipedia